Related Projects

Throughout the course of the project we will engage with other projects that are involved in similar studies.


REDDSTAR is an EU funded project which will develop and test stromal cell therapy to treat for diabetes mellitus. The objective is to control blood glucose while also addressing a range of diabetic complications.

Project Website:


MERLIN explores exciting new opportunities in stromal cell therapy R&D, while making important contributions to the treatment of currently intractable inflammatory and immune mediated liver diseases.

Project Website:


TRANSLINK is a project devoted to assessing the mid-to long-term risk factors and improve the outcome of animal (bovine/porcine)-derived Bioprosthetic Heart Valve (BHV) implants. 300,000 patients/year benefit from BHV, a major healthcare problem (second most frequent cardiac surgery).

Project Website:


The main objective of the European project Immodgel is to find innovative solutions to the frequent adverse immune reactions following implantation procedures. For this purpose, the consortium will create a personalised, immunomodulatory system that will be adjustable for any implant, medical device or transplant. 

Project Website:


The overall aim of this project is to clarify the mechanisms and identify nature´s own specific control points of regulation in these adverse reactions in order to be able to significantly improve the quality of hemodialysis devices and kidney grafts by applying these concepts of regulation in hemodialysis and kidney transplantation.

Project Website:


Nano Engineering for Cross Tolerance: new approach for bioengineered, vascularised, chimeric islet transplantation in non-immunosuppressed hosts..

Project Link: NEXT CORDIS Record


The aim of the HypOrth-project (hypoallergenic implant material in Orthopaedics) is the development of personalized implants that will last the patients whole life. Testing of the patients’ genes and immune system prior to the operation will allow the selection of the right implant materials thus avoiding adverse immunological reactions. During the project, gene tests and immunological biomarkers will be discovered, and hypo-allergenic materials and antimicrobial implant surfaces will be developed

Project Link: HypOrth

Arrest Blindness

Who are we? ARREST BLINDNESS is a consortium performing a four-year research project funded by the HORIZON 2020 program of the European Commission.

Project Link: Arrest Blindness


RESPINE will develop a rigorously proven, effective treatment of degenerative disc disease (DDD). Via a multicentre, randomized, controlled, phase 2b clinical trial including 112 patients with DDD, RESPINE will assess the efficacy of an allogenic intervertebral mesenchymal stem cell (MSC)-based therapy. The consortium aims to provide new knowledge on immune response & safety associated with allogeneic BM-MSC intradiscal injection. This simple procedure will be cost-effective, and minimally invasive.

Project Link: RESPINE


The SCIENCE project will conduct a multicentre, double-blind placebo-controlled trial with allogeneic adipose-derived stromal cells (CSCC_ASCs) to improve myocardial function in patients with ischemic heart disease and heart failure. In addition, SCIENCE will establish a manufacturing facility for centralised production of allogeneic CSCC_ASCs, and financial health care data to demonstrate the impact of implementing treatment with the proposed new CSCC_ASC product. The project will evaluate advanced existing and new imaging techniques in order to more precisely guide the delivery of stem cells

Project Link: SCIENCE